FDA investigation decreases opioid prescribing in children

FDA investigation decreases opioid prescribing in children PharmacoEconomics & Outcomes News 792, p11 - 2 Dec 2017 FDA investigation decreases opioid prescribing in children An investigation by the US FDA into opioid prescribing for children after tonsillectomy and/or adenoidectomy, which lead to a black box warning in February 2013, appears to have achieved a reduction in opioid prescribing for these patients, according to findings of a study published in Pediatrics. Truven MarketScan Commercial Claims and Encounters data were used to investigate prescribing of opioid analgesics (codeine, hydrocodone, oxycodone or others) within 7 days after tonsillectomy and/or adenoidectomy in 362 992 US children with private insurance who underwent this surgery between 2010 and 2015. There was a significant reduction in the proportion of patients who received one or more prescription fills for codeine between 2010 and 2015 (–13.3 percentage points). Overall, 31.0% of patients received one or more prescription fills for codeine in January 2010 compared with 5.1% in December 2015. The FDA investigation was associated with a nonsignificant reduction in the prescribing of opioids other than codeine (–1.2 percentage points). However, other factors lead to an increase in the proportion of children receiving alternative opioids, from 31.7% in January 2010 to 46.1% in December 2015. "Future quality-improvement efforts should focus on eliminating this residual inappropriate codeine prescribing and on encouraging the use of effective nonopioid medications such as ibuprofen," said the authors. Chua KP, et al. Effect of FDA Investigation on Opioid Prescribing to Children After Tonsillectomy/Adenoidectomy. Pediatrics : 16 Nov 2017. Available from: URL: http://doi.org/10.1542/peds.2017-1765 803284957 1173-5503/17/0792-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Dec 2017 No. 792 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics & Outcomes News Springer Journals

FDA investigation decreases opioid prescribing in children

1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial